A1 BioChem Labs Revenue and Competitors
Estimated Revenue & Valuation
- A1 BioChem Labs's estimated annual revenue is currently $6.2M per year.
- A1 BioChem Labs's estimated revenue per employee is $201,000
Employee Data
- A1 BioChem Labs has 31 Employees.
- A1 BioChem Labs grew their employee count by 29% last year.
A1 BioChem Labs's People
Name | Title | Email/Phone |
---|
A1 BioChem Labs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.8M | 29 | 4% | N/A | N/A |
#2 | $3.2M | 16 | 0% | N/A | N/A |
#3 | $83.2M | 414 | 7% | N/A | N/A |
#4 | $31M | 154 | 56% | N/A | N/A |
#5 | $66.6M | 265 | 0% | $35M | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -6% | N/A | N/A |
#8 | $165.7M | 216 | 14% | $250.7M | N/A |
#9 | $26.5M | 132 | -11% | $637.8K | N/A |
#10 | $49.4M | 246 | 6% | N/A | N/A |
What Is A1 BioChem Labs?
A1 BioChem Labs (ABCL) is a Contract Research Organization with three locations located in Wilmington, North Carolina and Hyderabad, India. Our primary focus is offering top notch custom synthesis chemistry services to Pharmaceutical Companies, Biotech’s, Universities, and Research Institutes. With an emphasis on speed, quality, communication, and pricing we provide customers with a reliable source for any chemistry needs.\n \nIn addition to custom synthesis work we also have an expanding catalog of compounds consisting of fine chemicals, scaffolds, and building blocks. Our collection consists of structurally diverse compounds that are useful to drug discovery and development efforts. With a focus on customer service we will provide you with a seamless experience.
keywords:N/AN/A
Total Funding
31
Number of Employees
$6.2M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 31 | -6% | N/A |
#2 | N/A | 31 | 244% | N/A |
#3 | $3.6M | 31 | 48% | N/A |
#4 | N/A | 31 | 24% | N/A |
#5 | N/A | 31 | 48% | N/A |